Skip to main content
Photo: med.miami.edu

University of Miami Multiple Sclerosis Center

Miami, Florida

Academic MS Center
11 Active TrialsLarge Center
27 MS centers statewide · Ranked #2 in Florida for clinical trials

At a glance

Infusion on site
Unknown
Clinical trials
11 active

What kind of place is this?

AI summary of this centre's website
Comprehensive Care TeamResearch FocusedPart of Major Health System

You are in an academic MS center where care is shaped by a multidisciplinary team and a strong university setting. You may appreciate the mix of MS treatment, education, and therapy support under one program. As a busy academic center, your care may involve coordination across several specialists.

Facility Profile

Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access2/5
Support Services5/5
Clinical Trials & Research3/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care2/5

About University of Miami Multiple Sclerosis Center

AI summary of this centre's website
This center combines MS care with the resources of the University of Miami and its Miller School of Medicine. It also stands out for its active involvement in multiple types of MS research.

The University of Miami Multiple Sclerosis Center focuses on diagnosing and treating multiple sclerosis in a university-based setting. You receive care from a multidisciplinary team that includes physicians, nurses, occupational therapy, physical therapy, speech therapy, and social workers. The center also supports educational seminars, web-based services, and resources for physicians caring for people with MS. Its research activity includes clinical, basic, and translational research, which may be helpful if you want care connected to an academic program.

The University of Miami Multiple Sclerosis Center is a dedicated MS division within the University of Miami Miller School of Medicine's Department of Neurology. You can expect care from a multidisciplinary team that includes physicians, nurses, and therapy and social work support. The center takes part in clinical, basic, and translational research, and offers educational seminars and web-based services for patients, families, and physicians.

Services & Treatments

What They Treat

multiple sclerosis

How They Treat It

diagnosis of multiple sclerosistreatment of multiple sclerosismultidisciplinary careeducational seminarsweb-based servicesresources for physiciansclinical research participationbasic research participationtranslational research

Diagnostics

diagnosis of multiple sclerosis

Research & Clinical Trials

This center is currently involved in 11 clinical trials — ranked #2 in Florida for active trials

A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
Ocrelizumab
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
Sanofi
Closed to new patientsPhase 3
TolebrutinibPlaceboTeriflunomide
Clinical Applications of Advanced Ophthalmic Imaging
University of Miami
Recruiting
Ocufolin
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RecruitingPhase 3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Closed to new patientsPhase 3
RemibrutinibTeriflunomide
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Closed to new patientsPhase 3
OfatumumabTetanus toxoid (TT) containing vaccine (Td, Tdap)13-valent pneumococcal conjugate vaccine (13-PCV)23-valent pneumococcal polysaccharide vaccine (23-PPV)Seasonal Quadrivalent influenza vaccineKeyhole limpet hemocyanin (KLH) neo-antigen
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Closed to new patientsPhase 3
Ofatumumab approved doseOfatumumab new dose
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Novartis Pharmaceuticals
Closed to new patientsPhase 3
Interferon beta-1aFingolimodPlacebo capsulePlacebo i.m. injection
Study of COYA 302 for the Treatment of ALS
Coya Therapeutics
RecruitingPhase 2
COYA 302Placebo
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
Johns Hopkins University
Closed to new patients
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod

Insurance & Access

Contact

1150 NW 14th Street Suite 609, Miami, FL 33136

Insurance & Support

FAQs from University of Miami Multiple Sclerosis Center

The center provides diagnosis and treatment for multiple sclerosis. Care is delivered through a multidisciplinary team that includes physicians, nurses, occupational therapy, physical therapy, speech therapy, and social workers.

Yes. The center supports clinical research participation, basic research participation, and translational research in multiple sclerosis.

Yes. The center offers educational seminars and web-based services for patients and families living with MS.

Yes. The center is affiliated with the University of Miami, the University of Miami Miller School of Medicine, and the Department of Neurology.

MS Centers Across the U.S.

Click a state to browse its MS treatment centers.

The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play
Call Website